Tech Company Financing Transactions
Hallux Funding Round
Private investors invested in a $1.3 million venture round for Hallux. The round was announced on 11/17/2018.
Transaction Overview
Company Name
Announced On
11/17/2018
Transaction Type
Debt
Amount
$1,255,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 8 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
23052 Alcalde Dr. A
Laguna Hills, CA 92653
USA
Laguna Hills, CA 92653
USA
Phone
Website
Email Address
Overview
Hallux, Inc. is a privately held clinical-stage pharmaceutical company focused on developing its lead product candidate HTS (Hallux Terbinafine Sublingual).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Taylor
Co-Founder
Jay Birnbaum
Browse more venture capital transactions:
Prev: 11/17/2018: Sift Healthcare venture capital transaction
Next: 11/17/2018: Zdaly venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs